Running on the GSP platform, the multiplex dried blood spot test identifies at-risk children prior to symptom onset.
Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified, multiplex autoantibody detection solution designed to enable population-wide screening programs that identify children at risk of developing type 1 diabetes before symptoms appear.
Type 1 diabetes is frequently diagnosed only after substantial beta-cell destruction has occurred, often presenting initially as an episode of diabetic ketoacidosis. The 3-plex assay uses capillary dried blood spots to support scalable sample collection and runs on Revvity’s GSP instrument, a high-throughput platform established in newborn screening workflows.
The end-to-end system integrates reagents, instrumentation, and software to detect at-risk pediatric individuals months or years ahead of clinical symptom onset, facilitating early intervention and access to disease-modifying therapies.
“The launch of the GSP T1D 3plex kit marks an important step forward for Revvity’s expansion into child health screening,” says Anna Godenhjelm, vice president and general manager of reproductive health at Revvity, in a release. “This milestone demonstrates how our expertise in newborn screening can be leveraged to advance earlier detection in new areas of healthcare.”
Support for Population-Level Screening Programs
The assay is designed to support emerging national type 1 diabetes screening initiatives, adding to the company’s broader diabetes portfolio that encompasses research, clinical testing, and service models.
Revvity plans to present details regarding both on-site installation options and off-site testing service solutions developed in collaboration with Sanofi at the European Association for the Study of Diabetes meeting in Milan, Italy.
The GSP T1D 3plex kit will initially roll out in Europe and other markets accepting CE-IVD-marked diagnostic products. The product is not cleared by the US Food and Drug Administration.
ID 62832849 © Pressmaster | Dreamstime.com
